Prof Simon Best
Simon is Chairman of ProMetic Inc., a Canadian Rare-Disease drug company quoted on the TSX. He previously built three substantial ventures – Zeneca Plant Science, Roslin BioMed and Ardana – and has a solid track record in financing and growing biotech companies. Simon is also an experienced Angel, Venture Capital and Private Equity Investor. Between 2005 and 2010, he was an Entrepreneur-in-Residence for TVM Capital’s MENA Fund in UAE and India and in 2008 co-founded PAR Equity LLP, an Edinburgh based investment syndicate. He is a past Vice-Chairman of the US Biotechnology Industry Organisation and Chairman of the UK BioIndustry Association. In 2008, he was awarded an OBE and appointed a Visiting Professor of Medicine by the University of Edinburgh.
Non Executive Director
Phil is the Director of Finance for the University of Edinburgh having joined the University in September 2012.
Prior to this he held a similar position at Heriot-Watt University and earlier in his career he undertook a range of roles at Scottish & Newcastle.
Phil was named Finance Director of the Year in the 2016 Business Insider Scottish Accountancy and Finance Awards
Dr Mike Capaldi
Mike has held senior roles in the pharmaceutical and life sciences industry since 1982, both in the UK and the USA. Previous large companies included Ciba Geigy, SmithKline & French and Amersham International where he headed up the Drug Development Services in the USA – later becoming an Executive Vice-President in Nycomed Amersham’s healthcare division. For the last 18 years, Mike has worked in the biotech/technology sector serving as executive director on the Boards of both publically listed and private companies including Core Group plc, Oxford Asymmetry plc, Mindweavers plc, Synaptica Ltd, Scancell plc, Hunter-Fleming Ltd and CMP Therapeutics Ltd (in the latter four companies as CEO). Mike is also currently a non-executive director of Stealthyx Therapeutics, Roslin Cells and Synaptica. He joined Edinburgh BioQuarter as Director in 2010 before founding Sunergos Innovations in October email@example.com +44 (0)131 651 7896
Chief Financial Officer
Iain was previously Finance Director of the National Trust for Scotland. Prior to this he had spells as Finance Director for Grant Management (UK) Ltd, Axway Software SA and Sopra Group. Before this he was Chief Operating Officer for Scottish Widows Investment Partnership (SWIP). Iain trained as a Chartered Accountant with KPMG Peat Marwick before moving on to become a corporate finance partner in Rutherford Manson Dowds CA.+44 (0)7916 799 233